Seasonal Allergic Rhinitis Clinical Trials

230 clinical trials for Seasonal Allergic Rhinitis across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study — RECRUITING · NA
• The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy — RECRUITING
• Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis — RECRUITING · PHASE2
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH PERENNIAL ALLERGIC RHINITIS — RECRUITING · PHASE3
• A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure — RECRUITING · PHASE2
• Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis — RECRUITING · PHASE2
• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis — RECRUITING · PHASE2
• Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis — RECRUITING · NA
• Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis — RECRUITING · PHASE2
• "A STUDY TO EVALUATE THE EFFICACY OF DUPILUMAB AS AN ADJUNCT FOR SUBCUTANEOUS GRASS IMMUNOTHERAPY TO REDUCE PROVOKED ALLERGIC RHINITIS SYMPTOMS USING THE NASAL ALLERGEN CHALLENGE MODEL" — RECRUITING
• A SINGLE-CENTRE, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL-GROUP, COMPARATIVE ENVIRONMENTAL EXPOSURE CHAMBER (EEC) STUDY TO EVALUATE EFFICACY, SAFETY AND TOLERABILITY OF TWO FIXED DOSE COMBINATION (FDC) PRODUCTS OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE NASAL SPRAY AS COMPARED TO THE FDC OF AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE NASAL SPRAY, OLOPATADINE NASAL SPRAY, AND PLACEBO IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS — RECRUITING
• EFFICACY AND SAFETY OF INTRANASAL S0597 IN AN ENVIRONMENTAL EXPOSURE UNIT MODEL OF SEASONAL ALLERGIC RHINITIS: A PHASE 2, SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO, AND ACTIVE-CONTROLLED PARALLEL GROUP STUDY — RECRUITING · PHASE2
• Study to Evaluate the Effect of the Coadministration of SCH 497079 (a Histamine 3 [H3] Receptor Antagonist) Plus Desloratadine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis Who Have Been Exposed to Pollen in the Vienna Challenge Chamber (VCC) — COMPLETED · PHASE2
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis — OTHER · PHASE3
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis — OTHER · PHASE3
• A randomised, double blind, 2-way crossover trial of 8 days repeat dosing with intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR) — COMPLETED · PHASE2
• A randomised, double-blind, placebo-controlled, 4-period incomplete block crossover study of single oral dose GSK835726 (100mg, 50mg, 10mg), Cetirizine (10mg) and placebo to evaluate the efficacy and safety using an Environmental challenge chamber in male subjects with seasonal allergic rhinitis. — COMPLETED · PHASE2
• EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG) — COMPLETED · PHASE3
• Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500) — OTHER · PHASE2
• A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal allergies — OTHER · PHASE4
• Cross-Over Study of the Decongestant Effect of Phenylephrine Compared With Placebo and Pseudoephedrine as Active Control in SAR Subjects Exposed to Pollen in the Vienna Challenge Chamber — COMPLETED · PHASE3
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067) — OTHER · PHASE3
• Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis — COMPLETED · NA
• Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · PHASE3
• A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · PHASE3
• Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · PHASE3
• An open label, balanced, randomized, single dose, two-treatment, four period, two-sequence, crossover, fully replicate, bioequivalence study comparing Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablet USP 180 mg/240 mg, Manufactured by: Sun Pharmaceutical Industries Limited, India with Allegra-D® 24 HR (Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets 180 mg + 240 mg) tablets, Distributed by: Chattem Inc., a Sanofi Company Chattanooga, TN 37409 — NOT_YET_RECRUITING · PHASE1
• An open label, balanced, randomized, single dose, two-treatment, two period, two-sequence, crossover, bioequivalence study comparing Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablet 180 mg/240 mg, Manufactured by: Sun Pharmaceutical Industries Limited, India with Allegra-D® 24 HR (Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets 180 mg + 240 mg) tablets, Distributed by: Chattem Inc., a Sanofi Company Chattanooga, TN 37409-0219, USA, in healthy, adult, human parti — NOT_YET_RECRUITING · PHASE1
• Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) — NOT_YET_RECRUITING · PHASE2
• Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · NA
• A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · PHASE2
• Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis — COMPLETED · PHASE2
• Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients — COMPLETED · PHASE3
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ENVIRONMENTAL EXPOSURE UNIT TRIAL OF INTRANASAL INI-2004 IN SUBJECTS WITH RAGWEED-INDUCED ALLERGIC RHINITIS — COMPLETED
• Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult — COMPLETED · PHASE2
• A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients — COMPLETED · PHASE1
• A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis — COMPLETED · PHASE3
• A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis — NOT_YET_RECRUITING · PHASE3
• A TWO-PART, ADAPTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, STUDY TO ASSESS THE APPROPRIATE DOSE AND THE APPROPRIATE DOSING FREQUENCY OF ALDP 001 IN ADULTS WITH SEASONAL ALLERGIC RHINITIS (SAR) ASSESSED USING AN ALLERGEN CHALLENGE CHAMBER/EEC — COMPLETED
• Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis — COMPLETED · PHASE2
• Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults — COMPLETED · PHASE2
• A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen — COMPLETED · PHASE3
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) — COMPLETED · PHASE4
• Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) — COMPLETED · PHASE3
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) — COMPLETED · PHASE4
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177) — COMPLETED · PHASE4
• Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) — COMPLETED · PHASE4
• Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519) — COMPLETED · PHASE3

Refine this search